Abstract:Objective To explore the protective effcets of Schisandra chinensis extract (SCE) in paraquat (PQ)-induced pulmonary fibrosis in mice ,and its intrinsic molecular mechanisms thereof. Methods A total of 108 mice were randomly allocated into six groups (n=18):control group, model group, low concentration of SCE group (200 mg/kg), medium concentration of SCE group (400 mg/kg), high concentration of SCE group (800 mg/kg) and vitamin C group (100 mg/kg). Except control group, mice were given by intragastric administration with PQ (100 mg/kg) and administered with SCE and Vitamin C once per 24 h after PQ modeling. Mice were sacrificed at 7, 14 and 21 d after modeling. Six mice were executed at different time points. The degree of lung tissue inflammation and fibrosis were observed by HE staining and Masson staining. The mRNA and protein expression levels of transforming growth (TGF)-β1, interleukin (IL)-6 and IL-17 in lung tissue were determined by RT-PCR and ELISA respectively. Results (1) Compared with control group, the lung tissue of model group showed a large number of inflammatory cell infiltration, space congestion, and its inflammation scores increased at 7 and 14 days after modeling (P<0.05). At the same time, compared with model group and vitamin C group, inflammation scores were significantly decreased in medium concentration of SCE group and high concentration of SCE group (P<0.05). (2) Compared with control group, collagen fibers and the degree of fibrosis were significantly increased in model group ,while pulmonary fibrosis were decreased in medium concentration of SCE group and high concentration of SCE group at 14 and 21 days after modeling (P<0.05). (3) With the extension of modeling time, both mRNA and protein expressions of TGF-β1 were obviously elevated, IL-6 decreased and IL-17 reduced after the first increase in PQ group. Compared with PQ group, levels of three cytokines mRNA and protein expression in medium concentration of SCE group and high concentration of SCE group changed as follows:IL-6 level was markedly decreased at 7 and 14 days after modeling;TGF-β1 level was markedly increased at 14 and 21 days after modeling. However, IL-17 level was markedly decrease at three time points(P<0.05). Conclusion SCE can relieve PQ-induced lung inflammation and fibrosis by suppressing TGF-β1, IL-6, and IL-17 expressions.

Anti-pneumoconiosis effect of schisantherin A in PMA-induced A549 cells and SiO2/TiO2nanoparticles-induced acute pulmonary injury in mice

Schisandrin A regulates the Nrf2 signaling pathway and inhibits NLRP3 inflammasome activation to interfere with pyroptosis in a mouse model of COPD

Alleviation of Severe Inflammatory Responses in LPS-exposed Mice by Schisantherin A

Schisantherin A Protects Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice Through Inhibiting NF-κB and MAPKs Signaling Pathways

Protective Effects of Schisandrin B on Cigarette Smoke-Induced Airway Injury in Mice Through Nrf2 Pathway.

Schisandra A Ameliorates Cigarette Smoke Extract and Lipopolysaccharide-Induced Oxidative Stress in Lung Epithelial Cells

Schisandrol A Alleviates Allergic Asthma in Mice via Regulating the NF-κB/IκBα and Nrf2/HO-1 Signaling Pathways

Sirt1 Protects Against Urban Particulate Matter-Induced Airway Inflammation

Schisandrin Improves Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting the Inflammatory Response in Vivo and in Vitro

Synergistic Protection of Schizandrin B and Glycyrrhizic Acid Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β1/Smad2 Pathways and Overexpression of NOX4.

Schisandrin B Attenuates Airway Inflammation and Airway Remodeling in Asthma by Inhibiting NLRP3 Inflammasome Activation and Reducing Pyroptosis

Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway

Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through the wingless/integrase-1 signaling pathway

Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary disease

N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis

Schisandrin Attenuates Lipopolysaccharide-Induced Lung Injury by Regulating TLR-4 and Akt/FoxO1 Signaling Pathways.

Evaluation of lung protection of Sanghuangporus sanghuang through TLR4/NF-κB/MAPK, keap1/Nrf2/HO-1, CaMKK/AMPK/Sirt1, and TGF-β/SMAD3 signaling pathways mediating apoptosis and autophagy

Schizandrin B alleviate bleomycin-induced pulmonary fibrosis

Protection of Schisandra Chinensis Extract in Paraquat-Induced Pulmonary Fibrosis in Mice

Schisandrin B protects against LPS-induced inflammatory lung injury by targeting MyD88

The Improvement Effect of Sodium Ferulate on the Formation of Pulmonary Fibrosis in Silicosis Mice Through the Neutrophil Alkaline Phosphatase 3 (NALP3)/Transforming Growth Factor-β1 (TGF-β1)/α-Smooth Muscle Actin (α-SMA) Pathway